Table: Kissei Pharm -2023/24 group results

Kissei Pharmaceutical

07/05/2024 07:00

May 7 (Reuters)- 
          Kissei Pharmaceutical Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Mar 31, 2024    Mar 31, 2023   Mar 31, 2025     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           75.58           67.49          83.00        41.00    
               (+12.0 pct)     (+3.2 pct)     (+9.8 pct)   (+10.9 pct) 
  Operating        4.02         loss 1.13         4.20         1.50    
                                              (+4.6 pct)   (-25.6 pct) 
  Recurring        6.14          598 mln          5.40         2.20    
              (+925.9 pct)     (+6.4 pct)     (-12.1 pct)  (-36.5 pct) 
  Net
  Net             11.16           10.53          11.30         5.20    
               (+6.0 pct)      (-18.5 pct)    (+1.2 pct)    (-8.4 pct) 
  EPS          246.61 yen      228.31 yen     255.62 yen    117.63 yen 
  Ann Div       82.00 yen       80.00 yen      90.00 yen               
  -Q2 Div       41.00 yen       40.00 yen      45.00 yen               
  -Q4 Div       41.00 yen       40.00 yen      45.00 yen               
  
  NOTE - Kissei Pharmaceutical Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4547.T